YouScript and Genome Medical Announce Partnership to Provide Clinical and Analytics Support for Genetic Risk Management

Connecting precision medicine analytics and genetic services

Seattle, WA – Today, YouScript Inc. and Genome Medical, Inc. announce a preferred partnership to provide end-to-end precision medicine solutions to health systems, insurance carriers and employers for the appropriate use of pharmacogenomics. Through the combined offering, organizations will have access to Genome Medical’s clinical care delivery platform that will now incorporate YouScript’s patented genetic risk score and clinical decision support to select appropriate pharmacogenomic testing and provide medication optimization guidance. In turn, YouScript will provide seamless access to testing guidance around the most actionable genes, interpretation and genetic counseling through Genome Medical.

Together, this will help remove barriers to personalized medication management, reducing adverse drug events and re-admission rates.

YouScript synthesizes all evidence impacting drug response to support the right decision at point of care by providing the safest, most effective medication management the current evidence allows. Partnering with Genome Medical will enable YouScript to leverage its technical and clinical experience and integrations in the clinical workflow in Epic, Cerner and Allscripts to extend that impact to genetic risk management beyond medications such as incorporation of the ACMG-59.

“YouScript and Genome Medical have a shared mission to bring clarity, accessibility and actionability to genomic data,” said Kristine Ashcraft, YouScript CEO. “By providing seamless access to both of our services, we are ensuring that all patients, providers and health systems can utilize more proactive medication management and the latest evidence-based genetic counseling to manage and reduce risk.”

“YouScript’s precision medicine tools and Genome Medical’s deep clinical genetics expertise are a dynamic combination to drive the appropriate use of pharmacogenomics,” said Lisa Alderson, co-founder and CEO, Genome Medical. “We see many areas of health care, such as mental health and cancer, where access to genomic information may help identify the right therapy faster.”

Genome Medical provides comprehensive genetic services and access to genetic testing through telehealth consultations and a genomic care delivery platform that connect people with a nationwide network of genetic specialists. These specialists provide personalized education about genetics, select and order tests, interpret results, provide actionable next steps and coordinate required follow up.


About Genome Medical

Genome Medical is a national telegenomics technology and services company bringing genomic medicine to everyday care. Through our nationwide network of genetic specialists and efficient genomic care delivery platform, we provide expert virtual genetic care for individuals and their families to improve health and well-being. We also help healthcare providers and their patients navigate the rapidly expanding field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care. We are shepherding in a new era of genomic medicine by creating easy, efficient access to top genetic experts. Genome Medical is headquartered in South San Francisco and is backed by Canaan Partners, GE Ventures, Illumina Ventures, Kaiser Permanente Ventures and HealthInvest Equity Partners. To learn more, visit and follow @GenomeMed.